Tag: OASIS 4
-

Oral Wegovy Pill Expands Across the US: Broad Availability and Weight-Loss Potential
Overview: Wegovy enters a new era as an oral GLP-1 option The obesity treatment landscape is changing again as Novo Nordisk’s Wegovy® becomes broadly available in an oral tablet form for adults in the United States. This marks the first and only oral glucagon-like peptide-1 (GLP-1) receptor agonist approved for weight management, offering a convenient…
-

Novo Nordisk’s Wegovy®: The First Oral GLP-1 Weight-Loss Pill Reaching Broad U.S. Availability
Introduction: A Milestone in Weight Management New options in weight management are always welcome for adults struggling with obesity and related health risks. Novo Nordisk has expanded access to Wegovy® (semaglutide) in an oral tablet form, marking the first and, so far, only oral GLP-1 therapy specifically approved for weight loss in adults. This shift…
